Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum food vacuole membrane lipid interface is a specialized microenvironment essential for the detoxification of heme during the parasite's erythrocytic cycle (Egan, 2008, Journal of Inorganic Biochemistry). As the parasite digests host hemoglobin within its acidic food vacuole, it releases large quantities of redox-active ferriprotoporphyrin IX (heme), which is toxic to the organism (Sullivan, 2002, International Journal for Parasitology). To survive, the parasite facilitates the biomineralization of heme into inert crystals known as hemozoin, a process catalyzed by lipids at the vacuolar membrane interface (Hempelmann, 2007, Pharmaceutical Reports). This site is the primary target for several classes of antimalarial drugs, most notably the quinolines such as chloroquine and amodiaquine. These drugs accumulate to high concentrations within the food vacuole and disrupt the crystallization process by binding to heme or the growing crystal surface at the lipid interface. The resulting accumulation of free heme leads to oxidative stress, membrane damage, and ultimately the death of the parasite. Despite the emergence of resistance mediated by membrane transporters like PfCRT, this interface remains a focal point for antimalarial drug discovery and development.
Inhibition of heme biocrystallization into hemozoin by binding to ferriprotoporphyrin IX (heme) or the crystal surface at the lipid-water interface, leading to the accumulation of toxic free heme.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum food vacuole membrane lipid interface.